Nomura Securities initiates coverage on Pharmacyclics (NASDAQ: PCYC) with a Buy. PT $137.00.

Analyst Ian Somaiya comments: "Pharmacyclics is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE